Overview

An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia

Status:
Completed
Trial end date:
2019-01-29
Target enrollment:
Participant gender:
Summary
An extension study of safety and tolerability of SEP-363856 in adult subjects with schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
Sunovion